Ubie vs Airdoc 鹰瞳科技
A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.
Ubie
Japan's free, doctor-supervised AI symptom checker, now with clinic AI...
Visit
|
Airdoc 鹰瞳科技
HK-listed retinal AI for chronic-disease screening and myopia care
Visit
|
|
|---|---|---|
| RECATOOLS Score | 7.8 / 10 | 6.8 / 10 |
| Capability | ||
| Value for money | ||
| Ease of use | ||
| ASEAN readiness | ||
| API quality | ||
| Pricing | Freemium | Custom |
| Free tier | Symptom checker free with no account; personalised report on possible causes and when to see a doctor | — |
| Paid from | Smart Support for US practices $850/mo; Japan hospital, pharma and enterprise plans quote-based | Screening quoted; the PBM myopia device is listed at ¥13,800 |
| Has API | ✗ | ✗ |
| Open source | ✗ | ✗ |
| Free to use | ✓ | ✗ |
| Users | 10M+ monthly users globally; 1,800+ medical institutions in Japan (2025) | — |
| Founded | 2017 | 2015 |
| Maker | Kota Kubo (engineer, ex-M3 Inc.) and Dr. Yoshinori Abe (physician) | — |
| Verdict | Ubie offers a genuinely useful, free and well-supervised symptom checker, and its move into AI phone agents for clinics has early validation from Mayo Clinic. Treat its accuracy claims carefully: the headline study is Ub... |
Airdoc's retinal AI has an unusually strong regulatory record: NMPA Class III approval for diabetic retinopathy in August 2020 and for retinal vein occlusion in April 2025, CE MDR certification for its fundus software, a... |
| Full review → | Full review → |
← Back to AI Directory
Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.